ACADIA Pharmaceuticals Inc (ACAD) reports a 32% annual revenue increase, driven by strong sales of DAYBUE and NUPLAZID, while expanding its pipeline and preparing for European market entry.

said it “stands ready to work together to bring the promise of the National Plan to fruition on behalf of everyone touched by Parkinson’s and atypical parkinsonisms.” “When we started the ...

Atypical Parkinsonism Center Digest is a free newsletter that goes out twice a year. Subscribers receive trusted information from the experts at the Johns Hopkins Parkinson’s Disease and Movement ...

Occasional atypical lymphomonocytoid cells were seen ... to the full regimen exhibited a relatively mild unilateral type of Parkinson's disease. The mechanisms by which the effects described ...

Hollywood’s biggest night returns with the 97th Oscars, ‘A Streetcar Named Desire’ pulls into Brooklyn, Gustave Caillebotte’s focus on the male form gets a closer look at the Getty Center, and more.

Parkinson’s disease dementia ... A healthcare professional may also prescribe atypical antipsychotics off-label. Off-label use is when doctors prescribe a drug for a purpose other than what ...

The program is growing and is open to anyone who has been diagnosed with typical Parkinson’s as well as individuals diagnosed with atypical forms of Parkinson’s including; Corticobasal Ganglionic ...

Detailed price information for Intra-Cellular Ther (ITCI-Q) from The Globe and Mail including charting and trades.

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

Everyone uses creative solutions throughout their day, without realizing it. From figuring out a route around heavy traffic to daydreaming about positive (or negative) things that might happen in ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...